Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
-
2181
-
2182
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2183
-
2184
-
2185
-
2186
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2187
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2188
-
2189
-
2190
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2191
-
2192
-
2193
-
2194
-
2195
-
2196
-
2197
-
2198
-
2199
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2200